Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparing Mortality, Revision Rates, and Patient-Reported Outcomes With Different Stem Lengths of the Lubinus SPII Cemented Hip Stem: A Target Trial Emulation.

NCT06367829 is registered in ClinicalTrials.gov with JointResearch as lead sponsor.

NCT NCT06367829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06367829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparing Mortality, Revision Rates, and Patient-Reported Outcomes With Different Stem Lengths of the Lubinus SPII Cemented Hip Stem: A Target Trial Emulation.
Lead sponsor
JointResearch
Phase
Observational
Overall status
Enrolling by invitation
Start date
January 8, 2024
Completion date
December 31, 2026
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

treatment outcome